Tetratherix, a medical device company backed by Xero founder Rod Drury, is set to float on the ASX this month, raising $25 million with an ambitious pitch to investors about the potential of its “medical Lego” product that helps the human body heal faster from injuries and surgery.
The company’s product has been in scientific development since 2011, and is built on the work of chief technical officer Ali Fathi, a biomolecular engineer who invented a new material that can be injected into wounds to help tissue and bones heal.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。